Standout Papers

Imbalanced Host Response to SA... 2007 2026 2013 2019 2.6k
  1. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 (2020)
    Daniel Blanco-Melo, Benjamin E. Nilsson-Payant et al. Cell
  2. A diverse range of gene products are effectors of the type I interferon antiviral response (2011)
    John W. Schoggins, Sam J. Wilson et al. Nature
  3. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry (2007)
    Matthew J. Evans, Thomas von Hahn et al. Nature
  4. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells (2009)
    Alexander Ploß, Matthew J. Evans et al. Nature
  5. Cellular cofactors affecting hepatitis C virus infection and replication (2007)
    Glenn Randall, Maryline Panis et al. Proceedings of the National Academy of Sciences

Immediate Impact

51 by Nobel laureates 22 from Science/Nature 64 standout
Sub-graph 1 of 15

Citing Papers

Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update
2023 Standout
1 intermediate paper

Works of Maryline Panis being referenced

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
2007 StandoutNatureNobel

Author Peers

Author Last Decade Papers Cites
Maryline Panis 2222 2051 2827 25 7.1k
Marcus J. Korth 1706 2079 1168 63 5.4k
Jianhua Sui 1777 3907 5547 75 11.4k
Andreas Wack 5158 2373 1857 82 8.2k
Rune Hartmann 4709 1794 2124 97 7.8k
John W. Schoggins 3892 1821 2290 72 7.8k
Michael R. Beard 1309 2179 900 84 4.9k
Rhea Sumpter 1607 3406 436 26 5.8k
Glenn Randall 1066 2365 1203 66 6.7k
I‐Chueh Huang 2379 1591 2294 26 5.0k
William M. Schneider 2107 916 1334 33 4.2k

All Works

Loading papers...

Rankless by CCL
2026